Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.